Publicacións en colaboración con investigadores/as de Hospital Universitario de Puerto Real (40)

2024

  1. Assessment of performance and comparison of three commercial HDV RNA detection assays: implications for diagnosis and treatment monitoring

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. Optimization of the molecular diagnosis of the acute hepatitis E virus infection

    Microbial Biotechnology, Vol. 16, Núm. 6, pp. 1325-1332

  2. “Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”

    European Journal of Surgical Oncology, Vol. 49, Núm. 10

2022

  1. HEPATITIS C VIRUS SCREENING AND LINKAGE TO CARE IN MENTAL HEALTH UNITS: AN OPPORTUNITY FOR HCV ELIMINATION

    Actas espanolas de psiquiatria, Vol. 50, Núm. 2, pp. 120-121

2021

  1. European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis

    Contact Dermatitis, Vol. 85, Núm. 2, pp. 186-197

  2. Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA index

    Contact Dermatitis, Vol. 84, Núm. 6, pp. 395-406

2020

  1. Current position of viral load versus hepatitis C core antigen testing

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, pp. 12-18

  2. Efficiency in patch testing: the number needed to test to get one relevant result as a new approach in the evaluation of baseline series

    British Journal of Dermatology

  3. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32

  4. Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 1, pp. 47-52

  5. Sample pooling for SARS-CoV-2 RT-PCR screening

    Clinical Microbiology and Infection, Vol. 26, Núm. 12, pp. 1687.e1-1687.e5

  6. Trend of relevant contact allergens of the feet in Spain over a period of 10 years

    Contact Dermatitis, Vol. 82, Núm. 4, pp. 211-217

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis

    Contact Dermatitis, Vol. 80, Núm. 5, pp. 263-272

  3. Increasing importance of european lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain

    Eurosurveillance, Vol. 24, Núm. 9

  4. Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?

    Actas Dermo-Sifiliograficas

  5. Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015)

    Contact Dermatitis, Vol. 80, Núm. 2, pp. 94-100

2018

  1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study

    Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82

  2. Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study

    Current HIV Research, Vol. 16, Núm. 6, pp. 425-435

2017

  1. Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study

    Contact Dermatitis, Vol. 76, Núm. 2, pp. 74-80